Stockscreener 앱 받기
73.06
0.84%
-0.62
시간 외 거래:
73.06
Praxis Precision Medicines Inc 주식(PRAX)의 최신 뉴스
Why Praxis Precision Medicines Stock Is Trading Higher Tuesday - MSN
Praxis Precision Medicines (NASDAQ:PRAX) Shares Gap Down Following Insider Selling - MarketBeat
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Shares Bought by CIBC Asset Management Inc - MarketBeat
Alex Nemiroff Sells 8,239 Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Stock - MarketBeat
Insider Selling: Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Insider Sells 5,188 Shares of Stock - MarketBeat
(PRAX) Proactive Strategies - Stock Traders Daily
Praxis Precision Medicines' general counsel sells shares worth $660,827 By Investing.com - Investing.com Canada
Praxis Precision Medicines principal accounting officer sells $424,318 in stock By Investing.com - Investing.com Australia
Praxis Precision Medicines' general counsel sells shares worth $660,827 - Investing.com
Praxis Precision Medicines principal accounting officer sells $424,318 in stock - Investing.com
Praxis Precision Medicines (NASDAQ:PRAX) Trading Down 7.9%Should You Sell? - MarketBeat
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Cormorant Asset Management's Strategic Acquisition in Praxis Pre - GuruFocus.com
Verition Fund Management LLC Adjusts Stake in Praxis Precision M - GuruFocus.com
Capital Research Global Investors Acquires New Stake in Praxis P - GuruFocus.com
Equities Analysts Offer Predictions for PRAX FY2024 Earnings - MarketBeat
FY2024 Earnings Estimate for PRAX Issued By HC Wainwright - MarketBeat
Praxis Precision Medicines Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
HC Wainwright Reiterates "Buy" Rating for Praxis Precision Medicines (NASDAQ:PRAX) - MarketBeat
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Q3 2024 Earnings Call Transcript - Insider Monkey
Praxis Precision Medicines Inc (PRAX) Is Worth A Look Now, Despite -5.10% Loss From High - Stocks Register
Praxis Precision Medicines Inc (PRAX) Q3 2024 Earnings Call Highlights: Strong Cash Position ... - Yahoo Finance
Praxis Precision Medicines Inc (PRAX) Q3 2024 Earnings Call Highlights: Strong Cash Position ... By GuruFocus - Investing.com Canada
Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2024 Financial Results - citybiz
Praxis Precision Medicines Reports Q3 2024 Results and Progress - TipRanks
Praxis Precision Medicines, Inc. (PRAX) Reports Q3 Loss, Misses Revenue Estimates - MSN
Praxis Precision Medicines to Participate in Three Upcoming November Investor Conferences - GlobeNewswire
Praxis Precision Medicines to Present at Three Major Healthcare Conferences in November | PRAX Stock News - StockTitan
Praxis Precision Advances CNS Disorder Therapies - TipRanks
Q3 2024 Praxis Precision Medicines Inc Earnings Call Transcript - GuruFocus.com
Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2024 Financial - The Bakersfield Californian
How the (PRAX) price action is used to our Advantage - Stock Traders Daily
Vanguard Group Inc's Strategic Acquisition in Praxis Precision M - GuruFocus.com
Assenagon Asset Management S.A. Decreases Stock Holdings in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat
Praxis Precision Medicines (PRAX) to Release Quarterly Earnings on Wednesday - MarketBeat
Praxis Precision Medicines to Announce Third Quarter 2024 - GlobeNewswire
Praxis Precision Medicines to Announce Third Quarter 2024 Financial Results and Host Conference Call on Wednesday, November 6, 2024 - The Manila Times
(PRAX) Trading Advice - Stock Traders Daily
Moody Aldrich Partners LLC Purchases 7,224 Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat
We're Not Very Worried About Praxis Precision Medicines' (NASDAQ:PRAX) Cash Burn Rate - Yahoo Finance
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Praxis Precision To Report Aria Study Data In June - RTTNews
Will Praxis Precision Hit The Targets? - RTTNews
Praxis Precision Medicines revises executive severance terms - Investing.com
Where are the Opportunities in (PRAX) - Stock Traders Daily
Praxis Precision Medicines revises executive severance terms By Investing.com - Investing.com Australia
Praxis Precision To Reveal Key Trial Data On Essential Tremors - RTTNews
Dimensional Fund Advisors LP Sells 8,152 Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat
Praxis Precision shares get boost on DEE space acquisition interest - Investing.com India
Praxis Precision Medicines (NASDAQ:PRAX) Reaches New 52-Week HighHere's Why - MarketBeat
Praxis Precision shares get boost on DEE space acquisition interest By Investing.com - Investing.com South Africa
0.93%
3.55%
자본화:
|
볼륨(24시간):